Twitxy Saved

André Zimerman

@AndreZimerman

Head of Clinical Trials, @hospitalmoinhos 🇧🇷 | Professor, PG Cardiology, @ufrgsnoticias 🇧🇷 | Fellowship, @TIMIStudyGroup 🇺🇸 | Lipids, Trials, Cardiology
🇧🇷 Porto Alegre, Brazil bio.site/andrezimerman Joined May 2016
845 Following 1.9K Followers 1.2K Posts

Latest posts 5

André Zimerman @AndreZimerman
Terrific thread, thank you for highlighting @FedericaFogacci!
Federica Fogacci @FedericaFogacci May 28
When TG reach ≥10 mmol/L, the question is no longer only lipid lowering. It is #pancreatitis prevention.
At #EASCongress2026, @AndreZimerman presents CORE TIMI 72a and CORE2 TIMI 72b data on #olezarsen in patients with TG ≥10 mmol/L and acute pancreatitis risk @TIMIStudyGroup
View quoted post on X
André Zimerman @AndreZimerman
One of my favorite projects at TIMI.

While exploratory, our findings support the concept that lowering LDL-C through PCSK9i may prevent the formation and progression of arterial aneurysms, including AAA.

Now in @CircAHA

@PrakritiGaba @marstonMD @BrianBergmark @TIMIStudyGroup
Circulation @CircAHA May 21
#Research letter: Earlier initiation of the PCSK9 inhibitor Evolocumab reduced the risk of arterial aneurysm events compared with delayed initiation in an analysis of the FOURIER trial ahajrnls.org/3PCdvbV
View quoted post on X
1 replies 3 reposts 12 likes 3.8K views View on X